États-Unis · Plateformes & données · Seeking Alpha

Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

Publié par Seeking Alpha · États-Unis il y a 4 h

Lire l'article complet sur Seeking Alpha Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (seekingalpha.com)

À lire aussi

The Motley Fool

Booking vs. Five Below: Is the Travel Giant or Specialty Retailer the Better Stock to Buy in 2026?

Parabilis Highlights 72% Response Rate, Maps Phase III Desmoid Trial for 2027

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Trump set to announce plan by Audi to build US factory in Georgia, source says

Berkshire Owns Both Chevron and Occidental. Which Oil Stock Is the Better Buy Now?

Myro (MYRO) Price Prediction: 2025, 2026, 2030